37 phenotypes from 4 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sh2b1em1(IMPC)Ics/Sh2b1+ C57BL/6N-Sh2b1em1(IMPC)Ics/Ics	impaired glucose tolerance	J:211773
Sh2b1tm1Ayos/Sh2b1tm1Ayos involves: C57BL/6	abnormal epididymis morphology	J:78931
	abnormal oocyte morphology	J:78931
	abnormal ovarian folliculogenesis	J:78931
	abnormal uterus development	J:78931
	absent tertiary ovarian follicles	J:78931
	asthenozoospermia	J:78931
	decreased body weight	J:78931
	decreased Leydig cell number	J:78931
	decreased ovary weight	J:78931
	decreased ovulation rate	J:78931
	decreased superovulation rate	J:78931
	decreased testis weight	J:78931
	normal endocrine/exocrine gland phenotype	J:78931
	normal immune system phenotype	J:78931
	increased secondary ovarian follicle number	J:78931
	neonatal lethality, incomplete penetrance	J:78931
	oligozoospermia	J:78931
	ovary hypoplasia	J:78931
	postnatal growth retardation	J:78931
	proportional dwarf	J:78931
	reduced female fertility	J:78931
	reduced male fertility	J:78931
	testis hypoplasia	J:78931
Sh2b1tm1Lr/Sh2b1+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6	hyperglycemia	J:92794
Sh2b1tm1Lr/Sh2b1tm1Lr involves: 129S1/Sv * 129X1/SvJ * C57BL/6	decreased body size	J:92794
	hyperglycemia	J:92794
	impaired glucose tolerance	J:92794
	insulin resistance	J:92794
	pancreatic islet hyperplasia	J:92794
	reduced fertility	J:92794
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL	abnormal pancreatic beta cell physiology	J:209019
	decreased circulating insulin level	J:209019
	decreased insulin secretion	J:209019
	decreased pancreatic beta cell mass	J:209019
	normal homeostasis/metabolism phenotype	J:209019
	impaired glucose tolerance	J:209019
	increased circulating glucose level	J:209019
	increased pancreatic beta cell proliferation	J:209019
	small pancreatic islets	J:209019